# US 2015/0104407 A1 · Protein-polymer-drug conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104407 A1
- Document ID: US20150104407A1
- Status: Published application
- Kind: A1
- Application number: 14/512,316
- Filed: 2014-10-10
- Published: 2015-04-16
- Earliest claimed: 2013-10-11
- Assignees: Mersana Therapeutics, Inc.
- Applicants: Mersana Therapeutics, Inc.
- Inventors: ALEKSANDR V. YURKOVETSKIY; MAO YIN; TIMOTHY B. LOWINGER; JOSHUA D. THOMAS; CHERI A. STEVENSON; VENU R. GURIJALA
- Web page: https://patentgrep.com/patent/US20150104407A1

## CPC

- A61K 47/6851: {the antibody targeting a determinant of a tumour cell}
- A61K 47/59: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K 47/6803: {Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates}
- A61K 47/68031: {the drug being an auristatin}
- A61K 47/68037: {the drug being a camptothecin [CPT] or derivatives}
- A61K 47/6811: {the drug being a protein or peptide, e.g. transferrin or bleomycin}
- A61K 47/6849: {the antibody targeting a receptor, a cell surface antigen or a cell surface determinant}
- A61K 47/6883: {Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy}
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A polymeric scaffold useful for conjugating with a protein based recognition-molecule (PBRM) to form a PBRM-polymer-drug conjugate is described herein. The scaffold includes one or more terminal maleimido groups. Also disclosed is a PBRM-polymer-drug conjugate prepared from the scaffold. Compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions are also described.

## Claims

### Claim 1

A polymeric scaffold of Formula (Id) useful to conjugate with a protein based recognition-molecule (PBRM):
wherein:
the scaffold comprises poly(1-hydroxymethylethylene hydroxymethyl-formal) (PHF) having a molecular weight ranging from about 2 kDa to about 40 kDa;
each occurrence of D independently is a therapeutic agent having a molecular weight of ≦5 kDa, and the
between D and the carbonyl group denotes direct or indirect attachment of D to the carbonyl group,
X is CH2, O, or NH;
m is an integer from 1 to about 300,
m1 is an integer from 1 to about 140,
m7 is an integer from 1 to about 40,
m3 is an integer from 1 to about 18, and
the sum of m, m1, m3, and m7 ranges from about 15 to about 300.

### Claim 2 (depends on 1)

The scaffold of claim 1, wherein the PHF has a molecular weight ranging from about 2 kDa to about 20 kDa, m7 is an integer from 1 to about 20, m3 is an integer from 1 to about 10, m1 is an integer from 1 to about 70 and the sum of m, m1, m3 and m7 ranges from about 15 to about 150.

### Claim 3 (depends on 1)

The scaffold of claim 1, wherein the PHF has a molecular weight ranging from about 3 kDa to about 15 kDa, m7 is an integer from 2 to about 15, m3 is an integer from 1 to about 8, m1 is an integer from about 2 to about 50 and the sum of m, m1, m3 and m7 ranges from about 20 to about 110

### Claim 4 (depends on 1)

The scaffold of claim 1, wherein the PHF has a molecular weight ranging from about 5 kDa to about 10 kDa, m7 is an integer from about 3 to about 10, m3 is an integer from 1 to about 5, m1 is an integer from about 5 to about 35 and the sum of m, m1, m3 and m7 ranges from about 40 to about 75.

### Claim 5 (depends on 1)

The scaffold of claim 1, wherein each occurrence of D independently is selected from an auristatin compound, a topoisomerase inhibitor, a calicheamicin compound, a vinca compound, a tubulysin compound, a duocarmycin compound, a pyrrolobenzodiazepine compound, a kinase inhibitor, a KSP inhibitor, a maytansinoid, a DNA-binding, alkylating or intercalating drug, a RNA polymerase inhibitor, a protein synthesis inhibitor; and analogs thereof.

### Claim 6 (depends on 1)

The scaffold of claim 1, having Formula (Ia)
wherein:
m2 is an integer from 1 to about 40,
the sum of m, m1, m2 and m3 ranges from about 15 to about 300.

### Claim 7 (depends on 6)

The scaffold of claim 6, wherein the PHF has a molecular weight ranging from about 2 kDa to about 20 kDa, m2 is an integer from 1 to about 20, m3 is an integer from 1 to about 10, m1 is an integer from 1 to about 70 and the sum of m, m1, m2 and m3 ranges from about 15 to about 150.

### Claim 8 (depends on 6)

The scaffold of claim 6, wherein the PHF has a molecular weight ranging from about 3 kDa to about 15 kDa, m2 is an integer from 2 to about 15, m3 is an integer from 1 to about 8, m1 is an integer from about 2 to about 50 and the sum of m, m1, m2 and m3 ranges from about 20 to about 110

### Claim 9 (depends on 6)

The scaffold of claim 6, wherein the PHF has a molecular weight ranging from about 5 kDa to about 10 kDa, m2 is an integer from about 3 to about 10, m3 is an integer from 1 to about 5, m1 is an integer from about 5 to about 35 and the sum of m, m1, m2 and m3 ranges from about 40 to about 75.

### Claim 10 (depends on 6)

The scaffold of claim 6, having Formula (A):
wherein:
the PHF has a molecular weight ranging from about 5 kDa to about 10 kDa;
m is an integer from 1 to about 75,
m1 is an integer from about 5 to about 35,
m2 is an integer from about 3 to about 10,
m3 is an integer from 1 to about 5, and
the sum of m, m1, m2 and m3 ranges from 40 to about 75.

### Claim 11 (depends on 1)

The scaffold of claim 1, further comprising a PBRM conjugated to the PHF via the maleimido group.

### Claim 12 (depends on 11)

The scaffold of claim 11, when conjugated to the PBRM being of Formula (Ie):
wherein:
one of Xa and Xb is H and the other is a maleimido blocking moiety, or Xa and Xb, together with the carbon atoms to which they are attached form a carbon-carbon double bond;
m3a is an integer from 0 to about 17,
m3b is an integer from 1 to about 8, wherein the sum of m3a and m3b is m3,
the sum of m, m1, m7, m3a, and m3b ranges from about 15 to about 300, and
m5 is an integer from 1 to about 10.

### Claim 13 (depends on 12)

The scaffold of claim 12, having Formula (Ib):
wherein the sum of m, m1, m2, m3a, and m3b ranges from about 15 to about 300; and
m5 is an integer from 1 to about 10.

### Claim 14 (depends on 13)

The scaffold of claim 13, wherein the PHF has a molecular weight ranging from about 2 kDa to about 20 kDa, the sum of m, m1, m2, m3a and m3b ranges from about 15 to about 150, m1 is an integer from 1 to about 70, m2 is an integer from 1 to about 20, m3a is an integer from 0 to about 9, m3b is an integer from 1 to about 8 and m5 is an integer from 2 to about 8.

### Claim 15 (depends on 13)

The scaffold of claim 13, wherein the PHF has a molecular weight ranging from about 3 kDa to about 15 kDa, the sum of m, m1, m2, m3a and m3b ranges from about 20 to about 110, m1 is an integer from 2 to about 50, m2 is an integer from 2 to about 15, m3a is an integer from 0 to about 7, m3b is an integer from 1 to about 8 and m5 is an integer from 2 to about 4.

### Claim 16 (depends on 13)

The scaffold of claim 13, wherein the PHF has a molecular weight ranging from about 5 kDa to about 10 kDa, the sum of m, m1, m2, m3a and m3b ranges from about 40 to about 75, m1 is an integer from about 5 to about 35, m2 is an integer from about 3 to about 10, m3a is an integer from 0 to about 4, m3b is an integer from 1 to about 5 and m5 is an integer from 2 to about 4.

### Claim 17 (depends on 13)

The scaffold of claim 13, having Formula (B):
wherein:
the PHF has a molecular weight ranging from 5 kDa to 10 kDa;
m is an integer from 1 to 75,
m1 is an integer from about 5 to about 35,
m2 is an integer from about 3 to about 10,
m3a is an integer from 0 to about 4,
m3b is an integer from 1 to about 5,
the sum of m, m1, m2, m3a, and m3b ranges from about 40 to about 75, and
m5 is an integer from 2 to about 4.

### Claim 18

A polymeric scaffold of Formula (Ic):
wherein:
the scaffold comprises PHF having a molecular weight ranging from about 2 kDa to about 40 kDa;
X is CH2, O, or NH;
m is an integer from 1 to about 300,
m6 is an integer from 2 to about 180,
m3 is an integer from 1 to about 18, and
the sum of m, m6, and m3 ranges from about 15 to about 300.

### Claim 19 (depends on 11)

A pharmaceutical composition comprising a scaffold of claim 11 and a pharmaceutically acceptable carrier.

### Claim 20 (depends on 11)

A method of treating a disorder in a subject in need thereof, comprising administering to the subject an effective amount of a scaffold of claim 11.
